In the context of Oltipraz intervention, we further downregulated NRF2 to validate the role of Oltipraz in simultaneously regulating endothelial cell senescence and intercellular junctions via the NRF2-HIF2α signaling pathway in diabetes. The gene discussed is EPAS1; the disease is diabetes mellitus.